Mediclinic appoints new board committees

Mediclinic appoints new board committees

Mediclinic, a healthcare group has announced a review of its composition of the Board Committees, the membership of the Committees will be as follows, with effect from 17 March 2017.

The company said in its disclosure the composition of its new committees as follow:

  • The Audit and Risk Committee will continue to be chaired by Desmond Smith and its other members will comprise Alan Grieve, Seamus Keating and Trevor Petersen.
  • The Remuneration Committee will continue to be chaired by Trevor Petersen and its other members will comprise Prof Dr Robert Leu and Seamus Keating.
  • The Nomination Committee will be chaired by Dr Edwin Hertzog and its other members will comprise Jannie Durand (with Pieter Uys as his alternate), Prof Dr Robert Leu, Trevor Petersen and Desmond Smith.
  • The Clinical Performance and Sustainability Committee will continue to be chaired by Dr Edwin Hertzog and its members will comprise Nandi Mandela, Danie Meintjes and Prof Dr Robert Leu.
  • The Investment Committee will continue to be chaired by Dr Edwin Hertzog and its other members will comprise Jannie Durand (with Pieter Uys as his alternate), Alan Grieve, Seamus Keating, Danie Meintjes and Jurgens Myburgh.
  • Mediclinic’s primary listing is on the Main Market of the LSE, with secondary listings on the JSE in South Africa and on the NSX in Namibia.

Mediclinic is a private hospital group with three operating platforms in Southern Africa (South Africa and Namibia), Switzerland and the United Arab Emirates.

Leave a Comment

Your email address will not be published. Required fields are marked *

*